There are provided compounds having a superior PHD2 inhibitory effect that are represented by general formula (I′):
(in the above-mentioned general formula (I′),
W, Y, R
2
, R
3
, R
4
, and Y
4
are as described hereinabove), or pharmaceutically acceptable salts thereof.
The present invention provides compounds of Formula (I): or a stereoisomer, or a pharmaceutically acceptable salt thereof, wherein all of the variables are as defined herein. These compounds are GPR120 G protein-coupled receptor modulators which may be used as medicaments.
Copper Catalyzed sp<sup>3</sup> C–H Etherification with Acyl Protected Phenols
作者:Tolani K. Salvador、Charles H. Arnett、Subrata Kundu、Nicholas G. Sapiezynski、Jeffery A. Bertke、Mahdi Raghibi Boroujeni、Timothy H. Warren
DOI:10.1021/jacs.6b09057
日期:2016.12.28
A variety of acyl protected phenols AcOAr participate in sp3 C-H etherification of substrates R-H to give alkyl aryl ethers R-OAr employing tBuOOtBu as oxidant with copper(I) β-diketiminato catalysts [CuI]. Although 1°, 2°, and 3° C-H bonds may be functionalized, selectivity studies reveal a preference for the construction of hindered, 3° C-OAr bonds. Mechanistic studies indicate that β-diketiminato